Cargando…

Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats

OBJECTIVES: This work evaluated chronic treatment with 17β-oestradiol (E(2)) and 17β-aminoestrogen pentolame (AEP) on prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), and fibrinogen concentration (FIB). Male (M) and ovariectomized (Ovx) Wistar rats were used t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemini, Cristina, Jaimez, Ruth, Medina-Jiménez, Martha, Ávila, María Estela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523504/
https://www.ncbi.nlm.nih.gov/pubmed/23248406
http://dx.doi.org/10.4103/0253-7613.103287
_version_ 1782253216628473856
author Lemini, Cristina
Jaimez, Ruth
Medina-Jiménez, Martha
Ávila, María Estela
author_facet Lemini, Cristina
Jaimez, Ruth
Medina-Jiménez, Martha
Ávila, María Estela
author_sort Lemini, Cristina
collection PubMed
description OBJECTIVES: This work evaluated chronic treatment with 17β-oestradiol (E(2)) and 17β-aminoestrogen pentolame (AEP) on prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), and fibrinogen concentration (FIB). Male (M) and ovariectomized (Ovx) Wistar rats were used to explore gender differences in the pharmacological response. MATERIALS AND METHODS: Rats (n = 12-18) were treated every third day during three months with E(2) (1, 10, 100 μg/kg), AEP (1, 10, 100, 500 μg/kg) or vehicle (propylenglycol 1 ml/ kg). PT, aPTT, TT, and FIB were measured using standardized techniques. RESULTS: Chronic treatment with E(2) in male rats increased PT (4-7%; P < 0.05), decreased aPTT (9%; 100 μg/kg; P < 0.05) and decreased TT (5% at 100 μg/Kg; P < 0.05). Chronic treatment with E(2) in ovariectomized female rats decreased PT (3-4%; P < 0.05), did not induce significant changes on aPTT and decreased TT in a dose dependent manner (12-27%; P < 0.05). Chronic treatment with AEP in male rats did not alter PT, increased aPTT in a dose dependent manner (5-16%; P < 0.05), and decreased TT (5%; 500 μg/Kg; P < 0.05) while in female ovariectomized rats it decreased PT (5-9%; P < 0.05), increased aPTT (8-13%; P < 0.05) and decreased TT (6-13%; P < 0.05). E(2) and AEP decreased FIB in M and Ovx animals. Decreases in FIB by E(2) were more pronounced in male (15-18% P < 0.05) than in ovariectomized rats (10-14% P < 0.05). E(2) showed more potency than AEP, lowering FIB at 1 and 10 μg/kg doses. Both estrogens decreased FIB in ovariectomized animals (E(2), 10-14%, P < 0.05; AEP, 9% P < 0.05) and were reverted by increasing dosage. CONCLUSIONS: Gender influenced response to chronic treatment with E(2) and AEP on hemostatic parameters. PT and aPTT were the most affected parameters, demonstrating non-equivalence in the pharmacological response of M and Ovx rats.
format Online
Article
Text
id pubmed-3523504
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35235042012-12-17 Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats Lemini, Cristina Jaimez, Ruth Medina-Jiménez, Martha Ávila, María Estela Indian J Pharmacol Research Article OBJECTIVES: This work evaluated chronic treatment with 17β-oestradiol (E(2)) and 17β-aminoestrogen pentolame (AEP) on prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), and fibrinogen concentration (FIB). Male (M) and ovariectomized (Ovx) Wistar rats were used to explore gender differences in the pharmacological response. MATERIALS AND METHODS: Rats (n = 12-18) were treated every third day during three months with E(2) (1, 10, 100 μg/kg), AEP (1, 10, 100, 500 μg/kg) or vehicle (propylenglycol 1 ml/ kg). PT, aPTT, TT, and FIB were measured using standardized techniques. RESULTS: Chronic treatment with E(2) in male rats increased PT (4-7%; P < 0.05), decreased aPTT (9%; 100 μg/kg; P < 0.05) and decreased TT (5% at 100 μg/Kg; P < 0.05). Chronic treatment with E(2) in ovariectomized female rats decreased PT (3-4%; P < 0.05), did not induce significant changes on aPTT and decreased TT in a dose dependent manner (12-27%; P < 0.05). Chronic treatment with AEP in male rats did not alter PT, increased aPTT in a dose dependent manner (5-16%; P < 0.05), and decreased TT (5%; 500 μg/Kg; P < 0.05) while in female ovariectomized rats it decreased PT (5-9%; P < 0.05), increased aPTT (8-13%; P < 0.05) and decreased TT (6-13%; P < 0.05). E(2) and AEP decreased FIB in M and Ovx animals. Decreases in FIB by E(2) were more pronounced in male (15-18% P < 0.05) than in ovariectomized rats (10-14% P < 0.05). E(2) showed more potency than AEP, lowering FIB at 1 and 10 μg/kg doses. Both estrogens decreased FIB in ovariectomized animals (E(2), 10-14%, P < 0.05; AEP, 9% P < 0.05) and were reverted by increasing dosage. CONCLUSIONS: Gender influenced response to chronic treatment with E(2) and AEP on hemostatic parameters. PT and aPTT were the most affected parameters, demonstrating non-equivalence in the pharmacological response of M and Ovx rats. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3523504/ /pubmed/23248406 http://dx.doi.org/10.4103/0253-7613.103287 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lemini, Cristina
Jaimez, Ruth
Medina-Jiménez, Martha
Ávila, María Estela
Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats
title Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats
title_full Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats
title_fullStr Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats
title_full_unstemmed Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats
title_short Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats
title_sort gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523504/
https://www.ncbi.nlm.nih.gov/pubmed/23248406
http://dx.doi.org/10.4103/0253-7613.103287
work_keys_str_mv AT leminicristina genderdifferencesinresponsetochronictreatmentwith17boestradioland17baminoestrogenpentolameonhemostasisinrats
AT jaimezruth genderdifferencesinresponsetochronictreatmentwith17boestradioland17baminoestrogenpentolameonhemostasisinrats
AT medinajimenezmartha genderdifferencesinresponsetochronictreatmentwith17boestradioland17baminoestrogenpentolameonhemostasisinrats
AT avilamariaestela genderdifferencesinresponsetochronictreatmentwith17boestradioland17baminoestrogenpentolameonhemostasisinrats